Verastem (VSTM) 2025 Conference June 04, 2025 04:20 PM ET Speaker0 One of the biotech analysts are here. Please join me and welcome Mr. Dan Patterson, CEO from Verastem for this FerroSat chat session. Welcome, Dan. Speaker1 Thanks. Great to be here. Speaker0 And congratulations on the recent approval for low grade SARS ovarian cancer. Before we get into details, maybe you could give us a brief intro for the company Verastem and this novel combo, the recent approval and your interesting pipeline. Speaker1 Su ...